partnerships that has enabled it to access the top-league of players in its sector, as proven by the names of its corporate clients, such as Pfizer, Novartis, Unilever, Merck, Sanofi-Aventis, and Amgen or institutional customers like ETH Zürich, Harvard Medical School, Chinese University of Hong Kong to cite only a few. Since its foundation in 2002, ITG has performed a spectacular, though organic, growth and is currently in a position to further embrace, not only the high-potential bioinformatics market and to consolidate its presence as a leading brand in the Life Sciences community, but also to expand in the personalized genomics clinical market.